Healthcare professionals emphasize the importance of vigilance in managing these side effects
Structural defects underlying protein dysfunction in human glucose-6-phosphate dehydrogenase A() deficiency
That is correct and it can bring about synergistic results
The authors categorized studies into three key current research hotspots including (1) the mechanism by which gut microbiota metabolites, such as trimethylamine N-oxide (TMAO), short-chain fatty acids (SCFA) or LPS, influence the progression of CHD, (2) microbiota-targeted therapy in CHD management and (3) dietary modification as a possible tool to decelerate the progression of CHD
Tang, X., Chen, G., Chen, L., and Li, J., Toxicon , 2019, vol